Related Experiment Videos
Levamisole treatment of a child with severe aphthous stomatitis and neutropenia
Insights
Levamisole treatment improved recurrent infections and aphthous stomatitis in a child with chronic neutropenia. The drug reduced symptoms and prevented infections, showing a positive impact on immune health.
Area of Science:
- Immunology
- Pharmacology
Background:
- Recurrent infections and aphthous stomatitis can significantly impact a child's quality of life.
- Chronic neutropenia presents a challenge in managing recurrent infections.
Observation:
- A 12-year-old girl experienced monthly profound neutropenia, recurrent infections, and aphthous stomatitis.
- Symptoms included mouth ulcers, sore throat, and jugular gland swelling.
Findings:
- Levamisole treatment led to milder aphthous stomatitis.
- The patient experienced fewer infections and symptoms during follow-up.
- A notable increase in monocytes was observed during neutropenic phases after treatment.
Implications:
- Levamisole demonstrates therapeutic potential for managing aphthous stomatitis in patients with neutropenia.
- This suggests a role for levamisole in modulating immune responses and improving outcomes in specific pediatric conditions.
- Further research may explore levamisole's efficacy in similar immune-related disorders.
Abstract:
The treatment of a 12-year-old girl with a lifelone history of recurrent infections and aphthous stomatitis is reported. A profound neutropenis, first noted at the age of 2 years, occurring at least every month was observed together with multiple mouth ulcers a sore throat and swelling of the jugular glands. Levamisole, originally described as an anthelmintic, has a beneficial effect on the symptoms of recurrent aphthous stomatitis. After levamisole treatment aphthous stomatitis was milder and in the 1-year follow-up period the patient was asymptomatic several times during a phase of obvious neutrophil depression. The child no longer complained of a sore throat with swelling of the jugular glands and the recurrent staphylococcal infections of the skin disappeared. After therapy a marked increase in monocytes at the moment of neutropenia was observed.